MTOR and cancer: Analysis of The Cancer Genome Atlas (TCGA) Pan-Cancer dataset showed that genes in the mTOR signaling pathway were among the most frequently mutated across 12 tumor types in a cohort of 3281 tumors, notably including breast, colorectal, lung, uterine corpus endometrioid, head and neck, and ovarian cancers [6].